Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Brinda Desiraju"'
1
Renal replacement therapy in patients on extracorporeal membrane oxygenation support: Who and how
Autor: Berhane Worku, Lilia Voevidko, Ivan Gambardella, Erin Iannacone, Mario Gaudino, Haleh Ebrahimi, Sandi Khin, Sergey Savy, Iosif Gulkarov, Nicos Hadjiangelis, Charles Oribabor, Brinda Desiraju
Publikováno v: The International Journal of Artificial Organs. 44:531-538
Patients undergoing extracorporeal membrane oxygenation (ECMO) support frequently develop renal failure requiring renal replacement therapy (RRT). RRT may be performed via a dialysis catheter based approach or via the ECMO circuit. We describe our ex
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a4ec318ff16637eacdb44e196f88e3
https://doi.org/10.1177/0391398820980451
Zobrazit plný text záznamu
2
The role of stents in hemodialysis vascular access
Autor: Aisha Shaikh, Nabil Haddad, Ammar Almehmi, Alian Al-Balas, Brinda Desiraju, Amy C. Dwyer
Publikováno v: The journal of vascular access.
Vascular access is the Achilles’ heel of dialysis therapy among patient with end stage kidney disease. The development of neointimal hyperplasia and subsequent stenosis is common in vascular access and is associated with significant morbidity. Perc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038e5a6b613bd5f54f096fc07be96715
https://pubmed.ncbi.nlm.nih.gov/33993804
Zobrazit plný text záznamu
3
Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients
Autor: Morrell M. Avram, Chinu M. Jani, Hiteshkumar Kapupara, Neal Mittman, Brinda Desiraju, Irfan Fazil, Jyoti Chattopadhyay
Publikováno v: Kidney International. 78:S41-S45
Diabetes is the most common cause of end-stage renal disease and an important risk factor for morbidity and mortality in dialysis patients. Glycemic control, utilizing serial measurement of glycosylated hemoglobin (HbA1c), is generally recommended to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e3d641cc0951cfe84a6f0ff72c1c8c
https://doi.org/10.1038/ki.2010.193
Zobrazit plný text záznamu
4
Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study
Autor: Brinda Desiraju, Jyoti Chattopadhyay, Kevin B Meyer, Morrell M. Avram, Neal Mittman
Publikováno v: Kidney International. 78:S33-S36
Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease. The management of SHPT commonly involves vitamin D, either calcitriol or newer analogs (paricalcitol or doxercalciferol), along with dietary phosphorus restricti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::242a7bcdfcaf5529c5fcd3cb589f8032
https://doi.org/10.1038/ki.2010.191
Zobrazit plný text záznamu
6
209 Serum Fructosamine (SF), But Not Glycosylated Hemoglobin (HbA1C), Predicts Long-Term Survival in Nondiabetic (NDM) Hemodialysis (HD) Patients (PTS)
Autor: Neal Mittman, Brinda Desiraju, Jyotiprakas Chattopadhyay, Morrell M. Avram, Swapna Vemulapalli
Publikováno v: American Journal of Kidney Diseases. 57:B69
SERUM FRUCTOSAMINE (SF), BUT NOT GLYCOSYLATED HEMOGLOBIN (HbA1C), PREDICTS LONG-TERM SURVIVAL IN NONDIABETIC (NDM) HEMODIALYSIS (HD) PATIENTS (PTS) Neal Mittman, Brinda Desiraju, Swapna Vemulapalli, Jyotiprakas Chattopadhyay, Morrell M. Avram. Avram
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4074ccb498f7664d17a50410332dc2a8
https://doi.org/10.1053/j.ajkd.2011.02.212
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje